Share Print Page
 

VENTURE CAPITAL & EMERGING COMPANIES

Nixon Peabody is one of the leading firms in the world in advising venture equity firms and the companies in which they invest. Venture capital investors and emerging companies compete in a world defined by risk and innovation. Finding lawyers with the knowledge to provide clear, steady guidance throughout the lifecycle of a deal is critical. With extensive experience on both the investor and company sides of the table, a thorough understanding of current market terms, and superior coverage of major venture markets, Nixon Peabody has the resources to help clients succeed.

Over the past eight years, Private Equity Analyst has ranked Nixon Peabody among the most active law firms for private equity and venture capital transactions (#17 in 2012), as well as for fund formation and investments (#3 in 2012). In addition, our attorneys have been recognized as leaders in the field by Chambers USA: America’s Leading Lawyers for Business and Best Lawyers in America.

With a long-standing presence in the venture capital community, Nixon Peabody delivers value at every stage of the investment cycle, including:

  • Fund formation          
  • Portfolio investments 
  • Venture capital and growth equity investments
  • Liquidity events          

Our experienced attorneys partner with clients to provide practical advice for negotiating venture capital deals and handling issues that arise during the due diligence process. We assist clients in analyzing investment opportunities, and our work with emerging companies enables us to present venture capital clients with opportunities that fit their investment profile and industry-specific criteria.

Investor representation

We represent venture capital and private equity sponsors in fund formation, portfolio investments, and exits. Our sophisticated practice is experienced in all types of financing structures. Our work with leading-edge industries enables us to alert our venture capital clients to investment opportunities in a variety of promising fields.

Emerging company representation

Our attorneys negotiate and structure venture capital funding deals and all types of strategic alliances and partnerships. We help emerging businesses and management teams know what to expect throughout the financing process and avoid common pitfalls. Our relationships with a broad network of investors nationwide enable us to negotiate the most favorable terms and conditions for all types of private equity issuance.

Nixon Peabody offers full-service support to emerging companies and represents the leading edge of tomorrow’s business community in areas such as:

  • Cleantech and nanotechnology
  • Energy
  • Health care
  • Interactive media and entertainment
  • Life sciences (biotech and medical devices)
  • Technology

Our in-depth industry experience and comprehensive legal services enable clients not only to execute venture financing deals, but also to protect and exploit intellectual property assets, solidify financial backing, establish alliances that enhance product development and competitive strength, and access the capital markets. We routinely serve as outside general counsel to many of our clients, complementing their management teams and offering guidance on business planning, organizational structure, and investor presentations.

Thought Leadership/Alerts

Webinar Recording: The New World of Raising Capital in Life Sciences
Originally recorded December 13, 2012 | December 14, 2012

Congress takes action to approve crowd-sourced equity financing
Private Equity Alert | January 9, 2012

. . . View all . . .

Press

Chambers Recognizes Leading Nixon Peabody Attorneys and Practices
March 14, 2013

Nixon Peabody Recognized as Leader by Dow Jones Private Equity Analyst
March 14, 2012

. . . View all . . .

Media Clips

    • Medical App Makers Await Regulator Checkups
      The Recorder | March 15, 2013

      Silicon Valley Global Business & Transactions partner Mavis Yee and Washington, DC, Health Services and Life Sciences partner Areta Kupchyk are featured throughout this article noting that the mobile medical app industry is awaiting formal regulatory guidelines from lawmakers.

    • Lawmaker Backs Measure to Ease Restrictions on Finders
      The Recorder | February 20, 2013

      Global Business & Transactions partner Mavis Yee discusses possible legislation in California that would ease capital-raising restrictions for companies statewide.

    • Attorney Discusses Concerns about FDA MMA Draft Guidance
      FierceMobileHealthcare | February 4, 2013

      Silicon Valley partner Mavis Yee discusses the U.S. Food and Drug Administration's expected final guidance for mobile medical application developers. Click here to read the article.

    . . . Hide Media Clips . . .

    Events

    Venture Capital & Emerging Companies